Pathogenetics Unit, Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
J Transl Med. 2010 Oct 5;8:91. doi: 10.1186/1479-5876-8-91.
Esophageal squamous cell carcinomas (ESCC) are usually asymptomatic and go undetected until they are incurable. Cytological screening is one strategy to detect ESCC at an early stage and has shown promise in previous studies, although improvement in sensitivity and specificity are needed. Proteases modulate cancer progression by facilitating tumor invasion and metastasis. In the current study, matrix metalloproteinases (MMPs) were studied in a search for new early detection markers for ESCC.
Protein expression levels of MMPs were measured using zymography in 24 cases of paired normal esophagus and ESCC, and in the tumor-associated stroma and tumor epithelium in one sample after laser capture microdissection (LCM). MMP-3 and MMP-10 transcripts in both the epithelium and stroma in five cases were further analyzed by quantitative reverse transcriptase polymerase chain reaction (qRT-PCR).
Gelatin zymography showed bands corresponding in size to MMP-2, MMP-3, MMP-9, and MMP-10 enzymes in each of the 24 cancer cases. MMP levels tended to be higher in tumors than paired normal tissue; however, only the 45 kDa band that corresponds to the activated form of MMP-3 and MMP-10 was strongly expressed in all 24 tumors with little or no expression in the paired normal foci. LCM-based analysis showed the 45 kDA band to be present in both the stromal and epithelial components of the tumor microenvironment, and that MMP-3 and MMP-10 mRNA levels were higher in tumors than paired normal tissues for each compartment.
Increased levels of MMPs occur in ESCC suggesting their up-regulation is important in esophageal tumorigenesis. The up-regulated gene products have the potential to serve as early detection markers in the clinic.
食管鳞状细胞癌(ESCC)通常无症状,直到无法治愈时才被发现。细胞学筛查是早期发现 ESCC 的一种策略,在以前的研究中已经显示出了希望,尽管需要提高灵敏度和特异性。蛋白酶通过促进肿瘤侵袭和转移来调节癌症的进展。在本研究中,研究了基质金属蛋白酶(MMPs),以期找到 ESCC 的新的早期检测标志物。
使用 24 对配对的正常食管和 ESCC 组织中的明胶酶谱法测量 MMP 的蛋白表达水平,并在激光捕获显微切割(LCM)后对一个样本中的肿瘤相关基质和肿瘤上皮进行测量。在 5 例中,通过定量逆转录聚合酶链反应(qRT-PCR)进一步分析上皮和基质中的 MMP-3 和 MMP-10 转录本。
凝胶电泳显示,24 例癌症病例中每种都有对应大小的 MMP-2、MMP-3、MMP-9 和 MMP-10 酶的条带。MMP 水平在肿瘤中比配对的正常组织中更高;然而,只有对应于 MMP-3 和 MMP-10 的激活形式的 45 kDa 条带在 24 个肿瘤中强烈表达,在配对的正常焦点中几乎没有或没有表达。基于 LCM 的分析表明,45 kDa 条带存在于肿瘤微环境的基质和上皮成分中,并且在每个部位肿瘤中的 MMP-3 和 MMP-10 mRNA 水平都高于配对的正常组织。
ESCC 中 MMP 水平升高表明其上调在食管肿瘤发生中很重要。上调的基因产物有可能作为临床早期检测标志物。